Neuromyelitis optica (NMOSD): vizsgálatok itt: Egyesült Államok
17 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleImpact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
- Where
- New York
- Életkor
- 18 év and over
- People
- 20
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT06780709 - No phaseTaking peopleObservational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
- Where
- Aurora
- Életkor
- 15 év and over
- People
- 60
- Run by
- Amgen
See details and how to joinNCT05909761 - 2. fázisTaking peopleEfgartigimod for the Treatment of Acute Optic Neuritis
- Where
- Boston
- Életkor
- 18 év and over
- People
- 20
- Run by
- Anastasia Vishnevetsky, MD, MPH
See details and how to joinNCT06453694 - 1. fázisTaking peopleA Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- Where
- Ann Arbor, Cleveland, Columbus, La Jolla, Milwaukee, New York, Omaha, Rochester
- Életkor
- 18 év and over
- People
- 100
- Run by
- TG Therapeutics, Inc.
See details and how to joinNCT06680037 - No phaseTaking peopleRegistry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
- Where
- Boston, Chapel Hill, Columbus, Milwaukee, Plano, Washington D.C.
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT05966467 - No phaseTaking peopleStudy of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder
- Where
- Dallas
- Életkor
- 18 év and over
- People
- 35
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT06398158 - 3. fázisTaking peopleA Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Where
- Denver
- Életkor
- 2 év to 11 év
- People
- 8 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05199688 · EU 2023-507817-85-00 - 4. fázisTaking peopleRituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD
- Where
- Boston
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07010302 - 1. fázisNot yet taking people in Egyesült ÁllamokA Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients
- Where
- Dallas
- Életkor
- 18 év to 60 év
- People
- 5
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07573332 - No phaseCsak meghívásosAcceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder
- Where
- Atlanta, Boston
- Életkor
- 18 év to 70 év
- People
- 30
- Run by
- MedRhythms, Inc.
See details and how to joinNCT06374264 - No phaseTaking peopleStem Cell Ophthalmology Treatment Study II
- Where
- Coral Springs, Westport
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- MD Stem Cells
See details and how to joinNCT03011541 - No phaseTaking peopleLongitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
- Where
- New York
- Életkor
- 18 év and over
- People
- 170
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT05982925 - No phaseTaking peopleStudy of Ultomiris® (Ravulizumab) Safety in Pregnancy
- Where
- Boston
- People
- 75 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644 - No phaseCsak meghívásosCorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Where
- Waltham
- Életkor
- 18 év and over
- People
- 800
- Run by
- CorEvitas
See details and how to joinNCT04886492 - 2. fázisTaking peopleStudy of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
- Where
- Boston, Dallas, La Jolla, Loma Linda
- Életkor
- 2 év to 17 év
- People
- 15 worldwide
- Run by
- Amgen
See details and how to joinNCT05549258 · EU 2023-510007-22-00 - No phaseTaking peoplePerformance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- Where
- Baltimore, Boston, Chapel Hill, Evanston, Las Vegas, Los Angeles, Oklahoma City, Sacramento, Tampa, Washington
- Életkor
- 18 év and over
- People
- 103 worldwide
- Run by
- Ad scientiam
See details and how to joinNCT05566769 - No phaseTaking peopleMS-ResearchBiomarkerS
- Where
- Los Angeles
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Cedars-Sinai Medical Center
See details and how to joinNCT05204459